AIM: A case control study was designed to assess whether the prevalence of ACE gene polymorphism has any role in the development of CAD. METHODS: The study included unrelated 217 cases with CAD and 255 healthy controls. PCR was done using primers followed by agarose gel electrophoresis for study of different ACE gene polymorphisms. Multiple logistic regression analysis was carried out to find association between studied genotypes and lifestyle as well as biochemical risk factors. RESULTS: Both DD [OR: 2.16; 95%CI: (60.60-67.40)] and ID [OR: 1.48; 95%CI: (93.28-97.72)] genotypes of the ACE gene showed significant associations in the development of CAD. Coexistence of diabetes and hypertension found to be risk modifier of the disease. Tobacco intake in various forms elevates the risk of the disease among the cases with risk genotypes. CONCLUSION: ID and DD genotypes of ACE gene came out to be predisposing factors for the CAD cases in our study population.
AIM: A case control study was designed to assess whether the prevalence of ACE gene polymorphism has any role in the development of CAD. METHODS: The study included unrelated 217 cases with CAD and 255 healthy controls. PCR was done using primers followed by agarose gel electrophoresis for study of different ACE gene polymorphisms. Multiple logistic regression analysis was carried out to find association between studied genotypes and lifestyle as well as biochemical risk factors. RESULTS: Both DD [OR: 2.16; 95%CI: (60.60-67.40)] and ID [OR: 1.48; 95%CI: (93.28-97.72)] genotypes of the ACE gene showed significant associations in the development of CAD. Coexistence of diabetes and hypertension found to be risk modifier of the disease. Tobacco intake in various forms elevates the risk of the disease among the cases with risk genotypes. CONCLUSION: ID and DD genotypes of ACE gene came out to be predisposing factors for the CAD cases in our study population.
Authors: Y Friedlander; P Arbogast; S M Schwartz; S M Marcovina; M A Austin; F R Rosendaal; A P Reiner; B M Psaty; D S Siscovick Journal: Atherosclerosis Date: 2001-05 Impact factor: 5.162
Authors: F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch Journal: Am J Hum Genet Date: 1988-11 Impact factor: 11.025
Authors: K Lindpaintner; M A Pfeffer; R Kreutz; M J Stampfer; F Grodstein; F LaMotte; J Buring; C H Hennekens Journal: N Engl J Med Date: 1995-03-16 Impact factor: 91.245
Authors: Ana I Freitas; Isabel Mendonça; Maria Brión; Miguel M Sequeira; Roberto P Reis; Angel Carracedo; António Brehm Journal: BMC Cardiovasc Disord Date: 2008-07-17 Impact factor: 2.298
Authors: Gustavo Salgado Duque; Dayse Aparecida da Silva; Felipe Neves de Albuquerque; Roberta Siuffo Schneider; Alinne Gimenez; Roberto Pozzan; Ricardo Mourilhe Rocha; Denilson Campos de Albuquerque Journal: Arq Bras Cardiol Date: 2016-10-27 Impact factor: 2.000